← Leaderboards
Shama Virani
International Agency For Res On Cancer
$541,269
Attributed
$860,720
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $638.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$860,720 · 2
By mechanism
U01$638,903 · 1
R03$221,817 · 1
Top collaborators
- Sidharth Venkata Puram3 shared
Most similar at International Agency For Res On Cancer
Same institution · by research overlap
- Paul Joseph Brennan$16,689,806
- Partha Basu$5,397,794
- Maribel Almonte$2,831,005
- James Dowling McKay$1,344,429
- Devasena Anantharaman$113,000
Others in their field
Other Emerging Leaders on “South America”
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
- Neeraja Putta · Fisher Bioservices, Inc.$7,571,551
- Yunda Huang · Fred Hutchinson Cancer Center$6,194,380
- Adam D Devore · Duke University$4,895,584
- Alicia Martin · Massachusetts General Hospital$4,367,584
- Bruno De Bezerril Andrade · Vanderbilt University Medical Center$4,131,200
Research focus
South AmericaEuropeIncidenceTumorHuman PapillomavirusAlcohol ConsumptionGeneticHuman Papillomavirus 16SamplingUnited StatesMalignant Oropharynx NeoplasmMalignant NeoplasmsCessation Of LifeBiological MarkersBiologicalAftercareCox ModelsAlgorithmsDemographicsDetectionClinical BiomarkersArtificial Intelligence BasedCellsClinical Center
Grant awards (5)
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$534,915
U01 · FY2025 · DE
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$75,000
U01 · FY2025 · DE
Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data$28,988
U01 · FY2025 · DE
Germline risk of oral and oropharyngeal cancers across diverse populations$108,394
R03 · FY2022 · DE · contact PI
Germline risk of oral and oropharyngeal cancers across diverse populations$113,423
R03 · FY2021 · DE · contact PI